Q4 2024 Corbion NV Earnings Call Transcript

Feb 27, 2025 / 10:00 AM GMT
Release Date Price: $22.85 (-3.18%)

Key Points

Positve
  • Corbion NV (CSNVF) achieved organic sales growth of 2.2% in 2024, driven by a volume mix increase of 5.2%.
  • The company reported a significant organic adjusted EBITDA growth of 23.3% year-over-year.
  • Free cash flow from continued operations reached €98.3 million, surpassing targets.
  • The health and nutrition segment saw strong growth, with an 18.5% increase in organic sales.
  • Corbion NV (CSNVF) maintained a high EBITDA margin of 29.9% in the health and nutrition segment, reflecting strong operational leverage and favorable product mix.
Negative
  • Raw material and freight prices were volatile throughout 2024, impacting cost predictability.
  • The functional ingredients and solutions segment experienced a negative impact on margins due to price declines following input cost relaxation.
  • The biomedical segment faced challenges with weaker demand in agrochemicals and softness in the semiconductor market.
  • The PLA joint venture faced significant pricing headwinds, resulting in a low EBITDA margin of 2.1% in Q4.
  • Corbion NV (CSNVF) anticipates potential impacts from tariffs on goods into the US, which could affect future pricing strategies.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CORB.AS - Corbion NV
Q4 2024 Corbion NV Earnings Call
Feb 27, 2025 / 10:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to the Corbion full year and 4th quarter 2024 conference call and webcast. This morning we published our full year results, and the press release and presentation can be found on the website at www.corbion.com Investor relationsinancial Publications.

Before we begin, please note that today's discussion will include forward-looking statements based on current expectations and assumptions. These statements will involve some risks and uncertainties that may cause actual results to differ materially from those expressed. Factors beyond our control, including market conditions, economic changes, and regulatory actions can impact outcomes. Cormian does not take. Undertake any obligation to update statements made in this call
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot